Navigation Links
Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
Date:11/9/2009

SAN DIEGO, Nov. 9 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Third Annual Canaccord Cardiovascular Conference on Tuesday, November 10.

The presentation by Scott Huennekens, president and chief executive officer, will begin at 1 p.m., Pacific Standard Time (4 p.m., Eastern Standard Time).

The presentation will be available through the conference website at http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2843940 and via the company's website at www.volcanocorp.com.

Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH® IVUS tissue characterization and ChromaFlo®. Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) and Forward-Looking IVUS systems and catheters. Currently, more than 4,700 Volcano IVUS and FM systems are installed worldwide, and more than half of Vol
'/>"/>

SOURCE Volcano Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
2. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
3. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
4. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
5. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
6. China National Medicines Corporation Issues Milestone Purchase Order for 12,000 STA Systems
7. China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou
8. MedCath Corporation to Hold Conference Call on Fourth Quarter Results
9. DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
10. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
11. Select Medical Holdings Corporation Announces Exercise of Underwriters Option to Purchase Additional Shares

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...EETING, Pa., Nov. 20 In...t questions why currently available medications de... ignored, ECRI Institute, an independent nonprofit...ce on Finasteride for Prevention of Prostate Canc...09, New York Times article, " Drugs to Deter Som...
(Date:11/19/2009)...nd, Nov. 19 Warner Chilcott plc (N...previously announced secondary offering of 20,000,...c of $22.25 per share. The selling shareholders i..., DLJ Merchant Banking, J.P. Morgan Partners (advi....P., certain other institutional investors and mem...
(Date:11/19/2009)... Taiwan, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm, ... ingredients (APIs), announced that its,Tainan fac...ification from,SafeBridge(R) Consultants, Inc. The...d proficiency in the safe handling of potent activ...o specific laboratories and,production areas used ...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Universal Health Services Inc Announces Dividend 51192 1Health Plans Continue to Select Health Integrated to Improve Member Health Reduce Costs 51189 1Health Plans Continue to Select Health Integrated to Improve Member Health Reduce Costs 51189 2Health Plans Continue to Select Health Integrated to Improve Member Health Reduce Costs 51189 3Health Plans Continue to Select Health Integrated to Improve Member Health Reduce Costs 51189 4Health Plans Continue to Select Health Integrated to Improve Member Health Reduce Costs 51189 5Help For Handicapped From New Company 51187 1
...ntial treatment for kidney cancer -, SEATTLE, Oct...ented positive Phase 1 interim data from a Phase 1...with Nexavar(R) (sorafenib) in,patients with renal...ial,suggests that the combination of IL-21 and sor...imilar to known toxicities of each agent alone.,Th...
...m(TM) Coronary Stent System Indicate, Positive Re...Bare Stent, BURLINGTON, Mass., Oct. 23 CorNova, ...rman & CEO of CorNova, presented,preliminary resul... Valecor,Platinum(TM) Coronary Stent System at the...endently-conducted preclinical studies,illustrated...
Other Medicine Technology:ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R) 2ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R) 3ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R) 4CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference 2
(Date:11/20/2009)... Senators and Congressmen in Competitive Re-ele...h Care Vote , Washington,...ressmen running for re-election next year in races...e Cook, may come to regret voting for House Speake... to a breaking Zogby International/ O’Leary ...
(Date:11/20/2009)...EM, N.C., Nov. 20 Samue...o redefine what it means to be "happy" during the ...h a specialty in family counseling and chair of th...ty, Gladding says research shows that it is the pr... even depression during the holidays. ,, That,s...
(Date:11/20/2009)...readings in children with chronic kidney disease o...or,s office visits increasing a child,s risk for ... Johns Hopkins Children,s Center and other institu...the Journal of American Society of Nephrology. ,...s obtained during regular doctor visits to reading...
(Date:11/20/2009)...ore severe cases than with seasonal flu , ...researchers are reporting that children with asthm...flu than seasonal flu. , "Asthma has been ident...ith pandemic H1N1 influenza, present in 21 percent...pton Allen and fellow researchers from the Hospita...
(Date:11/20/2009)... VIEW, Calif., Nov. 20 O...of system solutions to acute healthcare facilities... 21st Annual Piper Jaffray Healthcare Conference ..., Omnicell Speakers: Randall A. Lipps, founder, ...resident & CFO ,, Date: Tuesday, December...
Breaking Medicine News(10 mins):Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2
...fesaving benefit over bare-metal version, studies ...) -- Although arteries propped open by drug-coated...an those treated with bare-metal stents, the risk ...liminate concerns raised by an earlier study that ...
... In recognition of National Nurses Week 200...d to support clinicians serving patients in their ..., VA (Vocus) May 6, 2009 -- In conjunction with th...h RN Recognition Day and ends on the birthday of F...
...hasize need for improved mental health services an...egence Foundation announced today it awarded $390,...Idaho, Oregon, Utah and Washington. Five of the ei...ansformation grant program. , , "Encouraging Rege...
... 6 Cardinal Health, a global provider of products...vity of health care, today announced its board of ...olders to vote on a proposed employee stock option...or-value" exchange, where eligible employees who h...
...now has within its reach the potential to end pedi... meeting in Geneva, the Board of Directors of the ...a (Global Fund), today agreed to enhance the Fund,...e door to strategies and programs that will end pe...
...r Cross-Sector Solutions, Releases Strategy Report...milies, the pharmaceutical industry, patients, con...released a national strategy proposal to counter t... countered successfully by a coordinated, multi-se...
Other Medicine News:Health News:Drug-Coated Stents Better at Keeping Arteries Open 2Health News:Drug-Coated Stents Better at Keeping Arteries Open 3Health News:Home Care Delivered, Inc. Celebrates National Nurses Week 2009 in Recognition of America's 2.9 Million Registered Nurses 2Health News:Regence Foundation Grants $390,000 to Improve Health Care Safety Net 2Health News:Regence Foundation Grants $390,000 to Improve Health Care Safety Net 3Health News:Cardinal Health Board Proposes Employee Stock Option Exchange Program, Declares Regular Quarterly Dividend 2Health News:Cardinal Health Board Proposes Employee Stock Option Exchange Program, Declares Regular Quarterly Dividend 3Health News:Cardinal Health Board Proposes Employee Stock Option Exchange Program, Declares Regular Quarterly Dividend 4Health News:Cardinal Health Board Proposes Employee Stock Option Exchange Program, Declares Regular Quarterly Dividend 5Health News:GAA Applauds Global Fund's Decision to Accelerate Support for Treatment Strategies to Prevent Mother-to-Child Transmission of HIV 2Health News:Prescription Drug Abuse Poses Public Health Threat 2
Amsler Manual
VIKING Coronary Guide Catheter
...em is designed to provide easy and accurate stent ...osis and are at high risk for conventional surgery...otid Stent System is 6F sheath/8F guide catheter c...CULINK utilizes rapid exchange (RX) technology so ...
Cryomatic Cryosurgical System
Medicine Products: